






THE IMPACT OF STATE HEALTH INSURANCE PARITY LAWS ON 












A thesis submitted to Johns Hopkins University in conformity with the requirements for 













Statement of Problem: The implementation of the Patient Protection and Affordable Care 
Act (PPACA) of 2010 is expected to change the Substance Use Disorder (SUD) 
treatment system drastically through its expansion of federal parity protections on mental 
health and SUD benefits. However, the impact of previously existent state-specific parity 
laws on access to and use of SUD treatment has not been fully explored. In this study, we 
aim to compare initiation of substance use treatment between individuals in states with 
and without SUD parity laws in the year 2001, using longitudinal data from two waves of 
the National Epidemiologic Survey on Alcohol and Related Conditions that took place 
respectively in 2001-2002 and 2004-2005.  
Methods: Stabilized inverse probability of treatment weights were used in conjunction 
with survey weights to adjust for potential confounders. Logistic regression models were 
then used to compare odds of treatment initiation among individuals reporting past year 
substance use (but no past year substance use treatment) in states with SUD parity laws 
compared to states with no laws. Sub-analyses were performed to focus on individuals 
with lifetime history of SUD as well as to analyze separately alcohol users and other 
substance users. 
Results: Individuals reporting past year substance use at baseline in parity states had a 
1.55 higher odds of treatment initiation than those in states without SUD parity (95% CI: 
0.63-3.81). Individuals with lifetime history of SUD at baseline in parity states and 
current substance use had a 1.69 higher odds of treatment initiation than those in states 
without SUD parity (95% CI: 0.81-3.54). Individuals with lifetime history of AUD (no 
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other SUDs) at baseline in parity states and current substance use had a 4.61 higher odds 
of treatment initiation than those in states without SUD parity (95% CI: 1.27-16.77). 
Conclusions: Parity was only associated with significantly higher odds of SUD treatment 
initiation among those with lifetime history of AUD and current substance use. 
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The implementation of the Patient Protection and Affordable Care Act (PPACA) 
of 2010 is expected to have changed the substance use disorder treatment system through 
its expansion of federal parity protections for mental health and substance use disorder 
benefits. However, it is not known to what degree increased coverage of substance use 
disorder treatment will have resulted in greater treatment utilization after the PPACA’s 
enactment in 2014. The variety of state legislation that existed before the implementation 
of the PPACA provides an opportunity to explore the impact of previous parity laws on 
access to and use of substance use disorder treatment. 
 
1.1 SUBSTANCE USE DISORDERS 
Substance use disorders (SUDs) are a collection of medical conditions related to 
the use of one of 9 classes of substances. The 4th edition of the Diagnostic and Statistical 
Manual of Mental Disorders (DSM-IV), released in 1994, describes generally that 
substance dependence, one of the two forms of substance use disorder (SUD) is a “cluster 
of cognitive, behavioral, and physiological symptoms indicating that the individual 
continues using the substance despite significant substance-related problems.” More 
specifically, the DSM-IV considers 7 criteria related primarily to impairment and use, 
including reduced or lack of control around quantity and frequency of use, impairment in 
social and work life and inability to meet obligations, but also to physiological-related 
symptoms, such as withdrawal. Of these 7 criteria, 3 or more must have been met in the 
prior 12 months for a diagnosis of the disorder. Substance abuse, the other form of 
substance use disorder, applies to individuals who do not meet the criteria of substance 
dependence and considers four slightly different criteria relating to recurrent use despite 
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impairment in social and work life, use in hazardous situation, and legal problems 
relating to use, of which only one criteria must be met in the previous 12 months for a 
diagnosis of the disorder.1 
Substance use, particularly alcohol use, is very prevalent in the United States, 
with more than 138 million reporting past month alcohol use and more than 27 million 
reporting past month use of illegal substances in 2015, representing 51.7% and 10.1% of 
the population greater than 12 years of age respectively.2 A total of 66.7 million 
Americans (24.9% of the US population) reported binge drinking in the past month (more 
than 5 drinks on a single occasion for men, and greater than 4 for women) and 17.3 
million (6.5% of the population) reported binge drinking on more than 5 days in the past 
month.2 Across age strata, white individuals have an increased risk of alcohol use, as well 
as binge or heavy drinking.3,4,5,6 
Of all substance users in the US, 20.8 million are estimated to have an SUD, of 
whom 15.7 million are estimated to have an alcohol use disorder and 7.7 million are 
estimated to have an illicit drug use disorder (DUD) (~6% and ~3% of the population 
over the age of 12).2 Men are nearly twice as likely as women to have a SUD, and the 
prevalence of SUDs in the population peaks among 20-29 year-olds, with those who 
develop SUDs at younger ages more likely to have an SUD into later adulthood.7 Those 
who are married tend to have a lower incidence of both AUD as well as illicit DUDs.8,3  
 SUDs are associated with high rates of comorbid psychiatric disorders. Over a 
third of those with an SUD also have a comorbid DSM-IV disorder (any psychiatric 
illness), excluding developmental disorders, and over 10% of those with an SUD have a 
comorbid mental illness that substantially interferes with or limits one or more major life 
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activities (serious psychiatric disorder).2 In a national population sample, those with SUD 
in the prior 12 months had a 20% 12-month prevalence of mood disorders compared to 
8% for those without SUD.9 
 Substance use is also associated with a variety of negative physical health 
outcomes. Alcohol use alone is responsible for 4% of the global disease burden, being 
causally associated with a wide variety of ailments, from esophageal, liver and breast 
cancers to cardiovascular disorders such as ischemic heart disease.10 Drug poisoning 
(which includes overdose deaths as well as other accidental and intentional poisonings) 
has outnumbered deaths by firearms, motor vehicle crashes, suicide and homicide in the 
United States since 2009 to the present, with driving under the influence associated with 
thousands of additional deaths per year.11  
 
1.2 SUBSTANCE USE TREATMENT AND TREATMENT BARRIERS 
 Entry into treatment for SUDs is low. Of the 21.7 million Americans estimated to 
have needed substance use treatment in 2015, only 3.0 million received treatment (14.0% 
of those needing treatment) and only 2.3 million received treatment at a specialty facility 
(10.8%).2 Only 8% of individuals with AUD had past-year AUD treatment.12 In one 
study, Harris et al. found that co-occurring mental illness and SUD does not make 
individuals more likely to seek mental health treatment than individuals with only mental 
illness.13 However, Chen et al., using data from a nationally representative survey 
(National Survey on Drug Use and Health 2005-2010), found that participants with a past 
year major depressive episode and co-occurring SUD were more likely to seek mental 
health services of all types.14  
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 The most common place where individuals receive treatment is at 12-step mutual-
help meetings, with other common sources of care being detoxification wards, outpatient 
clinics, rehabilitation programs, and private professionals including physicians, 
psychiatrists, psychologists and social workers.12 Despite low treatment utilization, there 
is a wide variety of evidence supporting the benefits of some of the most common 
sources of SUD treatment, including peer self-help organizations, many psychosocial 
and/or behavioral treatments and even brief interventions by medical professionals.15 
There are a variety of barriers to entering or receiving substance use treatment, 
with financial barriers being of special importance. Using 6 years of the National Survey 
on Drug Use and Health (2005-2006), a nationally representative cross-sectional survey, 
Chen et al. found that, among participants with SUDs, financial barriers were the second 
most common barrier to treatment, after not being ready to stop using substances.16 Using 
a cross-sectional wave of the National Epidemiologic Survey on Alcohol and Related 
Conditions (2001-2002), Kaufmann et al. found financial barriers to be an important 
barrier to alcohol use treatment, with 10% of those with lifetime history of AUD only and 
20% of those with lifetime history of AUD and comorbid mood and anxiety disorders 
listing it as a barrier to receiving treatment.17 
 
1.3 HISTORY OF HEALTH INSURANCE PARITY LAWS FOR SUBSTANCE USE 
 States are able to and often do enact legislation that requires insurers to cover 
specific types of treatment and health conditions. For substance use, we can distinguish 
between three levels of state-mandated substance use treatment coverage. Mandated 
offerings laws require that insurers cover substance abuse treatment to the same level as 
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surgical or medical treatments if the insurers choose to offer coverage for substance use.  
Mandated benefits laws require that insurers cover substance abuse treatment to some 
specified level but not to the same level as surgical or medical treatments. Parity laws 
require that insurers cover substance abuse treatment to the same level as surgical or 
medical treatments. 
 Prior to the enactment of the Patient Protection and Affordable Care Act in 2014, 
a wide range of disparities in coverage existed between substance abuse treatment 
coverage and medical and surgical coverage. An early wave of states, especially in the 
South, in the late 1970s through the 1980s passed a variety of mandated benefit or 
mandated offering laws, especially in regards to alcohol abuse treatment. In the 1990s, 
states moved towards more comprehensive mandated benefit laws, culminating in the 
first substance abuse parity law passed in Vermont in 1997.18 While states continued to 
pass laws mandating substance abuse treatment coverage in the early 2000s, some states 
weakened requirements for insurers.18 
 The history of federal parity laws for substance abuse is much more recent. While 
President Bill Clinton oversaw the passage and enactment of the Mental Health Parity 
Act in 1996, no substance abuse treatment parity was enacted until 2008, at which point 
President George W. Bush signed the Paul Wellstone and Pete Domenici Mental Health 
Parity and Addiction Equity Act (MHPAE), which affected employer sponsored plans for 
employers with more than 50 employees. The MHPAE is a mandated offerings laws and 
requires employers, if they choose to offer behavioral health coverage (including 
substance abuse treatment), to offer it at the same levels as medical and surgical benefits. 
The law was also applied to Medicaid managed care, Medicare Advantage (if offered 
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through a group plan), state and local government plans, and the State Children’s Health 
Insurance Program. The MHPAE created minimum standards for states but did not 
supersede more stringent state-level parity laws.19 
The MHPAE was followed in 2010 by the Patient Protection and Affordable Care 
Act (PPACA). The PPACA addressed disparities in limits to both the amount of coverage 
(e.g., annual/lifetime limits, limited inpatient coverage) and the types of mental health 
and substance abuse conditions covered. As part of the PPACA, substance abuse 
treatment was defined as an essential health benefit, requiring that state exchanges must 
offer coverage. Additionally, this coverage must be at the same level as surgical and 
medical coverage, and this parity requirement applies not only to the state exchanges but 
also to Medicaid.20  
 
1.4 STUDY GOAL 
While the PPACA has greatly expanded coverage of substance use disorder 
treatment, it is not known to what degree it has resulted in greater treatment initiation. 
Unfortunately, there are limited data that provide information on SUD treatment 
utilization pre- versus post-PPACA. In addition, there has been a paucity of information 
regarding the potential impact of the pre-PPACA parity legislation on service use. 
Therefore, the goal of this study was to assess whether SUD treatment initiation differed 
between individuals living in states with SUD parity laws in the year 2001 relative to 
individuals living in states with no parity laws. Specifically, we hypothesized that 
individuals with SUD and/or AUD who reside in states with parity laws would be more 
likely to initiate treatment relative to those living in states without parity laws. Better 
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understanding of the influence of parity laws on treatment initiation can help us 








2.1 STUDY POPULATION 
 We used data from the National Epidemiologic Survey on Alcohol and Related 
Conditions, Wave 1 and Wave 2, which is a nationally representative, longitudinal survey 
of 43,093 United States residents conducted by the National Institute on Alcohol Abuse 
and Alcoholism (NIAAA).21,22 Wave 1 of the survey was conducted in 2001-2002, with 
Wave 2 conducted in 2004-2005. Blacks and Latinos were oversampled. The survey 
assesses 16 mood, anxiety and personality disorders, as well as alcohol and substance use 
and alcohol use and substance use disorders, using questions based on the Alcohol Use 
Disorder and Associated Disability Interview Schedule-IV, a structured diagnostic 
interview schedule with good reliability and validity in general population samples. 
Substance use is ascertained in the NESARC for the following classes of substances: 
alcohol; sedatives, tranquilizers, painkillers, stimulants; marijuana; cocaine, 
hallucinogens, inhalants, heroin; other medications and drugs including psychoactive 
drugs and steroids, and tobacco.21 
A total of 34,653 participants completed both waves of the survey, of whom 3,081 
lived in states either with full SUD parity or with no SUD parity. Our primary analytic 
population consisted of 1,571 individuals who reported past year substance use, not 
including tobacco use, at baseline, but had not received SUD treatment in the year prior 
to the baseline interview. Within this sample we also separately analyzed 1) individuals 
with alcohol use and no illicit drug use, and 2) individuals with illicit drug use with or 
without alcohol use. Next we analyzed individuals with a lifetime history of AUD and/or 
illicit DUD and current use. Within this subsample we also separately analyzed 1) 
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individuals with a lifetime history of AUD and no illicit DUD history and current use, 
and 2) individuals with a lifetime history of illicit DUD and current use, with or without a 
history of AUD [Table 1]. Individuals with a lifetime history of AUD or illicit DUD were 
theorized to be more likely to initiate treatment because of their history of more severe 
alcohol and/or drug use behavior. 
 
2.2 EXPOSURE (Independent Variable) 
Our primary exposure was the parity status of each participant’s state of residence 
in 2001-2005. We defined parity as: 
The state requires insurers to cover SUD treatment at the same levels as they do 
for medical and surgical treatments. (States: Connecticut, Delaware, Maryland, 
Vermont) 
We defined partial parity as: 
The state requires insurers to cover SUD treatment, but they may do so at a level 
not equivalent to medical and surgical treatments. (States: Arkansas, Hawaii, 
Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, 
Montana, Nevada, North Dakota, Oregon, Pennsylvania, Rhode Island, 
Tennessee, Texas, Washington) 
We defined weak parity as: 
The state may require insurers to cover specific SUDs but not all, may do so at a 
level not equivalent to medical and surgical treatments, or may only require 
certain levels of offerings for those insurers that choose to offer coverage. (States: 
Alabama, California, Colorado, Florida, Georgia, Illinois, Mississippi, Missouri, 
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Nebraska, New Jersey, New Mexico, New York, North Carolina, Ohio, South 
Carolina, South Dakota, Utah) 
We defined no parity as: 
The state neither requires insurers to cover SUD treatment nor does it stipulate to 
what levels SUD treatment must be covered if insurers choose to offer coverage. 
(States: Arizona, Idaho, Iowa, Oklahoma, Wyoming) 
We compiled information on state SUD parity laws from the Substance Abuse and 
Mental Health Services Administration18 as well as the National Conference of State 
Legislatures.23 We resolved any inconsistencies by referring to the state statutes 
themselves where possible. Our results are generally consistent with previous literature.24 
We have provided a complete listing of all state parity laws that we reviewed and where 
possible we have listed the statute number and provided links (See Appendix). We then 
characterized each state law according to our parity definitions. States with full parity and 
those with no parity were hypothesized to have the strongest potential difference in SUD 
treatment initiation between the baseline (wave 1) and follow-up (wave 2) interviews. 
Consequently, these were the states that were included in our principal analyses.  
 
2.3 OUTCOME (Dependent Variable) 
Our outcome of interest was any self-reported incident SUD treatment episode 
between Wave 1 and Wave 2 interviews of any one of the following treatment types: 
alcohol/drug detoxification ward/clinic; inpatient ward of psychiatric/general hospital or 
community mental health program; outpatient clinic (including day/partial patient 
programs); alcohol/drug rehabilitation program; emergency room; halfway 
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house/therapeutic community; crisis center; private physician, psychiatrist, psychologist, 
social worker, or any other professional; any other agency/professional; and/or 
methadone maintenance program. We did not include 12-step treatment initiation in our 
outcome, because the research focus was the assessment of treatment initiation that 




We used propensity score weighting to improve comparability of individuals in 
parity states compared to individuals in states without parity. We estimated the 
probability of living in a state with parity, partial parity, weak parity and no parity given 
an individual’s age, sex, ethnicity, race, education, employment status, household 
income, marital status and survey weight using generalized boosted models.25,26 We 
generated inverse probability of treatments weights (IPTWs) and stabilized them by the 
marginal probabilities of living in parity, partial parity, weak parity and non-parity states 
according to each individual’s state of residence. Survey weights were multiplied by the 
IPTWs, and logistic regression, accounting for the complexity of the survey design and 
structure, was used to assess SUD treatment initiation at follow-up among those living in 
states with SUD parity relative to those without parity for each of our analytic 
populations. All analyses were run in R Version 3.2.5 with the ‘survey’ and ‘twang’ 
packages. To assess the effectiveness of the IPTW in balancing the composition of the 
individuals residing in parity as compared with non-parity states, we compared the 
characteristics of the groups before and after applying the combined weights.  
12 
 
Application of inverse probability of treatment weighting in these analyses was quite 
successful as the groups in analyses under different treatment conditions were similar 






Among 16,344 participants with substance use at baseline, 693 lived in states with 
parity and 878 lived in states without parity. Individuals in states with no parity were 
significantly more likely to be Hispanic (21.2% to 8.2%), white (90.9% to 72.7%), 
employed or seeking employment (76.8% to 72.6%), and have a lower household income 
(56.7% with income less than $49,999 compared to 44.9%), but less likely to have 
completed college (38% to 49%) [Table 2]. After applying IPTWs, the individuals in 
states with no parity were only statistically significantly different from individuals in 
states with parity on ethnicity (p=0.039) [Table 3]. 
The adjusted odds (taking into account the IPTW) of entering treatment between 
waves 1 and 2 for those reporting past year substance use (alcohol and/or illicit drug use) 
in parity states was 1.55 times higher than the odds of those in states with no parity (95% 
CI: 0.63 to 3.81). For those reporting past year alcohol use (no illicit drug use), the 
adjusted odds of entering treatment in states with parity was 1.38 times higher than in 
states with no parity (95% CI: 0.49 to 3.86). For those reporting past year illicit drug use, 
the adjusted odds of entering treatment in states with parity was 1.04 times higher than in 
states without parity (95% CI: 0.36 to 2.96) [Table 5].  
For individuals with a lifetime history of SUD (AUD and/or illicit DUD) at 
baseline, the adjusted odds of entering into substance use treatment between waves 1 and 
2 in states with parity was 1.69 times higher than in states with no parity (95% CI: 0.81 to 
3.54). For individuals with a lifetime history of AUD (without history of other SUD), the 
adjusted odds of entering into substance use treatment between waves 1 and 2 in states 
with parity was 4.61 times higher than in states with no parity (95% CI: 1.27 to 16.77). 
14 
 
For individuals with a lifetime history of illicit DUD, the adjusted odds of entering into 
substance use treatment between waves 1 and 2 in states with parity was 1.24 times 
higher than in states with no parity (95% CI: 0.44 to 3.48). 
In supplemental analyses, we assessed treatment initiation for individuals with 
substance use and lifetime AUD and/or illicit DUD residing in states with partial and 
weak parity laws compared to those living in states with no parity. No appreciable 
associations of state residence with partial or weak parity with substance use treatment 





Living in a state with full parity had a positive association with SUD treatment 
initiation among substance users relative to those living in states without parity, although 
this association only met criteria for statistical significance among those with a lifetime 
history of AUD and not with other SUDs. These findings suggest that the inclusion of 
parity measures for SUD treatment within the PPACA have the potential to result in 
increased service initiation for substance users, particularly for those with lifetime history 
of AUD. 
Limited research has examined the effect of parity legislation on SUD treatment 
initiation. In a previous study, Wen et al. did find that the implementation of a parity law 
increased facility SUD treatment rates by 9%.24 That study was focused on facility rates, 
and not treatment seeking at the individual level. As such, Wen and colleagues’ study 
was limited to specific types of treatment facilities, only including specialty SUD 
treatment facilities, and could not account for multiple visits by a single individual 
different treatment facilities outside a single course of treatment. We did not detect a 
similar increase in incident SUD treatment initiation at the individual level among all 
substance users in the current study, likely due to limited power. McConnell et al., 
examining Oregon’s 2007 parity legislation, found increased alcohol treatment 
expenditures but no changes for other substances, which is consistent with our finding of 
larger effect sizes for alcohol users or substance users with lifetime history of AUD.27 In 
a supplemental analysis, we found that substance users with a lifetime history of AUD 
(and no history of illicit DUD) were significantly more likely to have completed college, 
less likely to be unemployed and looking for a job, and reported higher household income 
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compared to substance users with a lifetime history of illicit DUD. These characteristics 
may make substance users with a lifetime history of AUD more likely to be insured and 
therefore more likely to enter treatment with increased mandated coverage. 
A main strength of the present study is its use of a nationally representative 
sample to expand on previous literature that examined only subpopulations or state-
specific effects. Additionally, whereas the only previous national study of which we are 
aware, was limited to facility level effects. Our study was able to link parity laws to an 
increase in the number of individuals accessing treatment, and was able to assess the 
incidence of treatment initiation over time, utilizing the prospective study design of the 
NESARC. 
Due to a limited number of states whose parity status changed between the two 
waves of the NESARC, we were unable to test the effect of the implementation of a 
parity law on substance use treatment initiation. Instead, our framework compared 
initiation of treatment in states with parity to states without parity, which leaves the 
potential for confounding by state implementation. Although our IPTW weighting 
method adjusts for some of these differences, there is the possibility of residual 
confounding. Also, even using this framework, there was still a relatively small sample of 
substance users in the parity states, which reduced our power to detect small effects. 
In summary, we found evidence that SUD parity legislation is associated with an 
increase in SUD treatment initiation, particularly among those with only an AUD. As the 
discussion on healthcare reform continues to evolve, our findings lend additional support 
to the maintenance of parity provisions for SUD treatment in future legislation. Further 
work needs to examine the effect of SUD parity legislation in larger datasets with 
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potentially more power, as well as to probe the effects of mandatory offering and 





TABLE 1. INCLUSIONS AND EXCLUSIONS 
Total Individuals in Waves 1 & 2 of the NESARC: 34,653 
Excluded States with changes in parity status: Alaska, Maine, New 
Hampshire, Virginia, West Virginia, Wisconsin (n=2,129) 
32,524 
remaining 
Exclude individuals not in parity/no parity states (n=29,443) 3,081 remaining 
Exclude individuals currently in treatment at baseline (n=37) 3,044 remaining 
Analytic Samples 
1) Alcohol and/or substance use (primary analytic sample) 1,571 
    1.1) Alcohol use, no other substance use     1,400 
    1.2) Other substance use, with or without alcohol use     171 
2) Lifetime history AUD and/or SUD and current use 747 
    2.1) Lifetime history AUD, no other SUD history and current use     504 
    2.2) Lifetime history other SUD and current use, with or without 
history of AUD 













Birth Year (mean) 1957 1958 0.101 
Female (%) 50.5 48.2 0.36 




White 72.7 90.9 
 
American Indian 0.7 1.8 
 
Asian 2.2 0.7 
 
African American 21.5 3.5 
 
Pacific Islander 0.8 0.3 
 
Mixed Race 2.2 2.7 
 
Education (%) <0.001 
Less than high school 0.07 0.11 
 
Completed high school / GED 0.23 0.27 
 
Some college 0.21 0.24 
 
College or greater 0.49 0.38 
 
Employment (%) 0.017 
Employed 70.1 73 
 
Unemployed (seeking employment) 2.5 3.8 
 




Other 5.6 2.8 
 
Household Income (%) <0.001 
<25,000 16.5 25.9 
 
25,000-49,999 28.4 30.8 
 
50,000-79,999 24.5 25.2 
 
>80,000 30.6 18.2 
 
Marital Status (%) 0.127 
Married 49.5 54.7 
 
Living with someone as if married 4.6 4.4 
 
Widowed 4.6 4.2 
 
Divorced 12.4 13.8 
 
Separated 2.3 2.3 
 











Birth Year (mean) 1956 1956 0.925 
Female (%) 49.9 48.8 0.701 




White 81.3 85.1 
 
American Indian 0.9 1.5 
 
Asian 1.5 0.8 
 
African American 13.5 9.9 
 
Pacific Islander 0.5 0.3 
 





Less than high school 7.9 9.4 
 
Completed high school / GED 25.3 25.3 
 
Some college 21.9 22.4 
 





Employed 71.6 72.6 
 
Unemployed (seeking employment) 2.6 3.7 
 




Other 4.6 3.3 
 
Household Income (%) 
  
0.316 
<25,000 19.4 22.8 
 
25,000-49,999 29.9 30.7 
 
50,000-79,999 25.4 24.7 
 
>80,000 25.4 21.8 
 
Marital Status (%) 
  
0.87 
Married 51.5 53.6 
 
Living with someone as if married 4.4 4.3 
 
Widowed 4.2 4.6 
 
Divorced 12.7 13.4 
 
Separated 2.5 2.3 
 






























    






Lifetime history of AUD without history of 





Lifetime history of SUD with or without history 
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Lifetime history of SUD with or without history 











STATE SUD PARITY STATUTES18,23,24 
 State  Statute  Date  Description  Insurance 
Type 
Type  

































Group  Parity 
California   1990  Alcohol  Group   



















Delaware   2001 Substance use 
disorders 
(amendment)  
  Parity  
















1988 Alcohol and 
drug abuse 
























Kansas    1998     Minimum 
mandated 
benefit 
Kansas    2002     Minimum 
mandated 
benefit 
Kansas 40.2, 105; 
40-2, 105a 





  Minimum 
mandated 
benefit 
Kentucky   1980  Alcohol    Mandated 
offering  
Kentucky    2000 Substance use 
disorders 
  Mandated 
offering  


















Maine   2003 Substance use 
disorders 
(amendment) 
   Parity 










Maryland   2002 
  



















Michigan 550.1414a  1982  Substance 
abuse  
Group, HMOs 




Michigan   2001 Substance use 
disorders  
  Minimum 
mandated 
benefit  
Minnesota    1986 Substance use 
disorders  
  Minimum 
mandated 
benefit  













1975  Alcoholism 
treatment  
Group  Minimum 
mandated 
benefit  












Missouri    1997      Mandated 
offering 






2015  Mental Health 
and Chemical 
Dependency 



















Montana    2001 Substance use Group Minimum 
mandated 
benefit 



















Nevada   1997  Substance use 
disorders 





  2003 Substance use 
disorder 
(amendment) 
  Minimum 
mandated 
benefit  









New Jersey   2002  Substance use 
disorders  
  Mandated 
offering  
New Mexico   1987 Alcoholism    Mandated 
offering  
New Mexico  59A-23-6; 
59A-47-35 
1999  Alcohol 
dependency 
 Group Mandated 
offering 
New York    1998 Substance use 
disorders 
 Group Mandated 
offering 
New York 3221(1)(5) 
(A)  
 2011 Alcoholism 
and substance 
abuse 
 Group Mandated 
offering  
N Carolina   1985  Substance use 
disorders  
 Group Mandated 
offering  






























Oregon   1981  Alcohol  Individual Mandated 
offering  







Oregon  743A.168; 
743.556  







Pennsylvania   1989 Substance use 
disorders 
  Minimum 
mandated 
benefit 
Pennsylvania 40 908-1 to 
908-8 








Rhode Island    2002 (Amendment) Group Minimum 
mandated 
benefit 
S Carolina 38-71-737 1976 Substance 
abuse 
 Group Mandated 
offering  
S Carolina   1994 Substance use 
disorders 
  Mandated 
offering 
S Dakota    1979  Alcohol   Mandated 
offering 




Texas   1981  Substance use 
disorders  
















Vermont   1998 Substance use 
disorders 
  Parity  
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Vermont 8.4089b  2011 Substance 
abuse 
  Parity 





















 Group Minimum 
mandated 
benefit 
W Virginia   1998  Alcoholism   Mandated 
offering 
Wisconsin   2004     Mandated 
offering 
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